Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis

NCT02019758 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: Oral Viscous Budesonide
DRUG: Fluticasone MDI
DRUG: Placebo slurry
DRUG: Placebo inhaler

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]